Landscape Capital Management L.L.C. Raises Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Landscape Capital Management L.L.C. increased its stake in UnitedHealth Group by 19.6% in the first quarter, bringing its total shares to 13,262, valued at approximately $6.95 million.
• Several institutional investors, including GAMMA Investing LLC and Vanguard Group Inc., significantly modified their holdings in UnitedHealth Group, with GAMMA raising its position by an astounding 56,142.1%.
• UnitedHealth Group recently reported quarterly earnings, missing analysts' estimates with $4.08 earnings per share and generated revenue of $111.62 billion, which was slightly below forecasts.

Landscape Capital Management L.L.C. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,262 shares of the healthcare conglomerate's stock after buying an additional 2,173 shares during the quarter. UnitedHealth Group comprises about 0.6% of Landscape Capital Management L.L.C.'s holdings, making the stock its 24th biggest holding. Landscape Capital Management L.L.C.'s holdings in UnitedHealth Group were worth $6,946,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of UNH. GAMMA Investing LLC lifted its position in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC purchased a new stake in UnitedHealth Group in the 1st quarter valued at $3,846,764,000. Vanguard Group Inc. raised its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $303.94 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market cap of $275.27 billion, a PE ratio of 13.17, a price-to-earnings-growth ratio of 1.94 and a beta of 0.43. The firm's fifty day simple moving average is $288.09 and its 200-day simple moving average is $384.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the company earned $6.80 earnings per share. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several analysts recently commented on UNH shares. Truist Financial reduced their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.